Evidence map›Paper›PMID 24455368›Full record

ArticleCase reports in orthopedics2013

Three Metachronous Osteosarcomas within 22 Years without Pulmonary Metastases: A Case Report and Review of the Literature.

Ulrike Michaela Pirker-Frühauf, Jörg Friesenbichler, Katharina Rabitsch, Bernadette Liegl-Atzwanger, Thomas Bauernhofer, Reinhard Windhager, Andreas Leithner

Open access · goldAbstract read
In one paragraph

Article in Case reports in orthopedics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ulrike Michaela Pirker-FrühaufDepartment of Orthopaedic Surgery, Medical University of Graz, Auenbruggerplatz 5-7, 8036 Graz, Austria.
Jörg FriesenbichlerDepartment of Orthopaedic Surgery, Medical University of Graz, Auenbruggerplatz 5-7, 8036 Graz, Austria.
Katharina RabitschDepartment of Orthopaedic Surgery, Medical University of Graz, Auenbruggerplatz 5-7, 8036 Graz, Austria.
Bernadette Liegl-AtzwangerDepartment of Pathology, Medical University of Graz, Auenbruggerplatz 25, 8036 Graz, Austria.
Thomas BauernhoferDivision of Oncology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.
Reinhard WindhagerDepartment of Orthopaedic Surgery, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Wien, Austria.
Andreas LeithnerDepartment of Orthopaedic Surgery, Medical University of Graz, Auenbruggerplatz 5-7, 8036 Graz, Austria.
Medical University of Graz · ATMedical University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction. We present the extremely rare case of a patient with three metachronous osteosarcomas within 22 years without evident pulmonary manifestation of disease 30 years after first diagnosis. Case Presentation. In 1983, a high-grade osteosarcoma of the left distal femur was diagnosed in an 18-year-old Caucasian male. He received rotationplasty accompanied by pre- and postoperative chemotherapy. Ten years later, an osteoblastic osteosarcoma occurred in TH12. En bloc resection and pre- and postoperative chemotherapy followed. In 2005, the patient developed another high-grade osteosarcoma in his right distal femur. Treatment included a wide resection and reconstruction with a tumour endoprosthesis as well as (neo)adjuvant chemotherapy. After the third tumour occurrence, cytogenetic and molecular genetic examinations (p53, rb1) were performed, showing a normal genetic pattern. Screening for metastases never showed clinical evidence of extraskeletal tumour manifestation. Discussion. In patients presenting metachronous osteosarcoma, identification of their lesions clonality (second primary tumour or metastases) could lead to a better understanding of tumour development and help to filter patients who need extended long-term followup due to a higher risk of late occurring sarcoma recurrence.

Identifiers

PMID24455368
PMCPMC3886224
OpenAlexW1982873114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.